Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,129.58
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,261.50
(
-0.78%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: joethdo post# 118096

Tuesday, 04/12/2011 2:10:24 PM

Tuesday, April 12, 2011 2:10:24 PM

Post# of 257253

I assume that a company like MNTA will be a big beneficiary of this trend also.

For MNTA, branded generics are plan B; plan A is to develop generic generics, i.e. generic biologics that are fully substitutable for their branded counterparts and do not have to be actively marketed—see #msg-26837144.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now